Infectious risk when prescribing rituximab in patients with hypogammaglobulinemia acquired in the setting of autoimmune diseases.
Boumaza X, Lafaurie M, Treiner E, Walter O, Pugnet G, Martin-Blondel G, Biotti D, Ciron J, Constantin A, Tauber M, Puisset F, Moulis G, Alric L, Renaudineau Y, Chauveau D, Sailler L.
Boumaza X, et al. Among authors: renaudineau y.
Int Immunopharmacol. 2023 Jul;120:110342. doi: 10.1016/j.intimp.2023.110342. Epub 2023 Jun 3.
Int Immunopharmacol. 2023.
PMID: 37276827